Related Experiment Video
Updated: Jan 17, 2026

Preparation of Single-cell Suspensions for Cytofluorimetric Analysis from Different Mouse Skin Regions
Published on: April 20, 2016
Modulation of the gut-skin axis by polysaccharides: Mechanisms and therapeutic potential in immune-related skin
Chen Haiming1, Liao Yijing2, Tang Bin3
1State Key Laboratory of Traditional Chinese Medicine Syndrome, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China; State Key laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, China.
Abstract:
Immune-related skin diseases are a group of conditions directly driven by the abnormal activation or dysregulation of the immune system. Current clinical treatments for these diseases frequently exhibit limited target specificity, suboptimal sustained efficacy, and potential adverse effects. As an emerging immunomodulatory "organ", gut microbiota has been confirmed by clinical data as a feasible method for the therapy of immune-related skin disorders. Therefore, it is imperative to explore the specific mechanisms by which gut microbiota affects immune-related skin diseases. As potent immunomodulatory agents, accumulating evidence has confirmed that polysaccharides are closely related to gut microbiota. At the same time, researches on polysaccharides targeting gut microbiota for the management of immune-related skin disorders are also increasing annually. This work endeavored to provide a comprehensive summary and exploration of the mechanisms by which gut microbiota affected immune-related skin diseases, and the effect of polysaccharides on gut microbiota. To elucidate the mechanisms by which polysaccharides modulated the gut-skin axis in treating immune-related skin diseases, thereby offering novel therapeutic insights and advancing clinical research and applications.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents